PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

SHE:301230 Revenue

PharmaResources (Shanghai) had revenue of 186.39M CNY in the quarter ending September 30, 2026, with 15.29% growth. This brings the company's total for the last twelve months to 724.75M, up 8.58% year-over-year. In the year 2025, PharmaResources (Shanghai) had annual revenue of 688.35M with 26.43% growth. That makes PharmaResources (Shanghai) the 22,027th largest company in the world by revenue and 4,023rd in China.

• Revenue (ttm): 724.75M
• Revenue Growth: +8.58%
• P/S Ratio: 8.12
• Revenue / Employee: 627.49K
• Employees: 1,297
• Market Cap: 5.89B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Drug Discovery 396.98M 57.7%
• Commercial Production 197.91M 28.8%
• Process Research and Development 63.71M 9.3%
• Unallocated Others 29.76M 4.3%

By Geography

Chart

• Foreign 476.46M 69.2%
• China 211.89M 30.8%

Fiscal year ended Dec 31, 2025 See the full SHE:301230 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	688.35M	143.88M	26.43%
Dec 31, 2024	544.47M	54.75M	11.18%
Dec 31, 2023	489.72M	10.83M	2.26%
Jan 1, 2023	478.88M	30.67M	6.84%
Jan 1, 2022	448.21M	165.22M	58.39%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error